Skip to main content
Premium Trial:

Request an Annual Quote

Ipsen, BioMérieux Partner on Theranostics Approach to Cancer

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Ipsen and BioMérieux today announced a collaboration using a theranostics approach to focus on hormone-dependent cancers.

The two French firms will combine their expertise and resources to co-develop therapeutics and companion diagnostic tests. The collaboration will leverage Ipsen's broad portfolio of compounds and BioMérieux's diagnostic tests and focus on prostate and breast cancers, neuroendocrine tumors, and pituitary tomors.

Financial and other terms of the deal were not disclosed.

"Our goal is to reinforce personalized medicine and contribute through this partnership to the novel paradigm in medicine, which is increasingly 'patient driven' rather than 'disease driven,'" Christian Bréchot, vice president of Institut Mérieux, in charge of medical and scientific affairs, and a member of BioMérieux's board, said in a statement.

Ipsen and BioMérieux have a relationship dating back to September 2007, when they announced a deal under which BioMérieux would develop a companion assay to determine which patients were the best candidates for Ipsen's steroid sulfatase enzyme inhibitor BN83495 (Irosustat). The compound is currently in phase I clinical development for the treatment of breast and prostate cancers and in phase II development for the treatment of advanced endometrial cancer.

The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.